Cocrystal Pharma, Inc. Common Stock
Veridion Score
Composite trend over time
Why is COCP moving today?
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for COCP.
COCP insider activity
Cocrystal Pharma, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for COCP.
COCP contract awards, year to date.
Public federal awards linked to this ticker.
COCP lobbying filings, year to date.
Registered lobbying filings matched to Cocrystal Pharma, Inc. Common Stock.